Psychosis in frontotemporal dementia

Journal of Alzheimer's Disease

Volumn 42, Issue 2, 2014, Pages 485-499

  Shinagawa, Shunichiro ^a,b   Nakajima, Shinichiro ^c,d,e   Plitman, Eric ^d,f   Graff Guerrero, Ariel ^d,e   Mimura, Masaru ^c   Nakayama, Kazuhiko ^b   Miller, Bruce L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Frontotemporal dementia; gene mutation; neuropathology; psychosis; schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; C9ORF72 PROTEIN, HUMAN; GRN PROTEIN, HUMAN; PROTEIN; SIGNAL PEPTIDE;

ARTICLE; DELUSION; DISEASE ASSOCIATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HALLUCINATION; HUMAN; NEUROIMAGING; PREVALENCE; PSYCHOSIS; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TDP 43 PROTEINOPATHY; BIBLIOGRAPHIC DATABASE; COMPLICATION; GENETICS; PSYCHOTIC DISORDERS; STATISTICS AND NUMERICAL DATA;

DATABASES, BIBLIOGRAPHIC; FRONTOTEMPORAL DEMENTIA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEINS; PSYCHOTIC DISORDERS;

EID: 84916879294     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140312     Document Type: Article

References (122)

1. Shinagawa S (2013) Phenotypic variety in the presentation of frontotemporal lobar degeneration. Int Rev Psychiatry 25, 138-144.
2. Ratnavalli E, Brayne C, Dawson K, Hodges JR (2002) The prevalence of frontotemporal dementia. Neurology 58, 1615-1621.
3. Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP (2011) The diagnostic challenge of psychiatric symptoms in neurodegenerative disease. J Clin Psychiatry 72, 126-133.
4. Bhat R, Rockwood K (2011) Psychiatric complications of dementia. Can J Psychiatry 56, 398-407.
5. Matsumoto N, Ikeda M, Fukuhara R, Shinagawa S, Ishikawa T, MoriT,ToyotaY, MatsumotoT, Adachi H, Hirono N,Tanabe H (2007) Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community. Dement Geriatr Cogn Disord 23, 219-224.
6. Ihl R, Frölich L, Winblad B, Schneider L, Burns A, Möller H-J (2011)World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of Alzheimer's disease and other dementias. World J Biol Psychiatry 12, 2-32.
7. Mendez MF, Shapira J, Woods RJ, Licht EA, Saul RE (2008) Psychotic symptoms in frontotemporal dementia: Prevalence and review. Dement Geriatr Cogn Disord 25, 206-211.
8. Snowden J, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM, Jones M, Gerhard A, Davidson YS, Robinson A, Gibbons L, Hu Q, DuPlessis D, Neary D, Mann DM, Pickering-Brown SM (2012) Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135, 693-708.
9. Sha SJ, Takada LT, Rankin KP, Yokoyama JS, Rutherford NJ, Fong JC, Khan BK, Karydas A, Baker MC, DeJesus- Hernandez M, Pribadi M, Coppola G, Geschwind DH, Rademakers R, Lee SE, Seeley WW, Miller BL, Boxer AL (2012) Frontotemporal dementia due to C9ORF72 mutations: Clinical and imaging features. Neurology 79, 1002-1011.
10. Mahoney CJ, Beck J, Rohrer JD, Lashley T,Mok K, Shakespeare T, Yeatman T, Warrington EK, Schott JM, Fox NC, Rossor MN, Hardy J, Collinge J, Revesz T, Mead S, Warren JD (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: Clinical, neuroanatomical and neuropathological features. Brain 135, 736-750.
11. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus- Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker MC, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Boot B,KuntzKM,Gavrilova R, ReevesA,Whitwell JL, Kantarci K, Jack CR, Parisi JE, Lucas JA, Petersen RC, RademakersR (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135, 765-783.
12. Harciarek M, Malaspina D, Sun T, Goldberg E (2013) Schizophrenia and frontotemporal dementia: Shared causation? Int Rev Psychiatry 25, 168-177.
13. Miller BL, Cummings JL, Villanueva-Meyer J, Boone KB, Mehringer CM, Lesser IM, Mena I (1991) Frontal lobe degeneration: Clinical, neuropsychological, and SPECT characteristics. Neurology 41, 1374-1382.
14. Miller BL, Chang L, Mena I, Boone KB, Lesser IM (1993) Progressive right frontotemporal degeneration: Clinical, neuropsychological and SPECT characteristics. Dementia 4, 204-213.
15. The Lund, Manchester Group (1994) Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 57, 416-418.
16. Neary D, Snowden J, Gustafson L, Passant U, Stuss D, Black SE, Freedman M, Kertesz A, Robert PH, Albert M, Boone KB, Miller BL, Cummings JL, Benson DF (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51, 1546-1554.
17. Gregory CA, Hodges JR (1996) Clinical features of frontal lobe dementia in comparison to Alzheimer's disease. J Neural Transm Suppl 47, 103-123.
18. Swartz JR, Miller BL, Lesser IM, Booth R, Darby A, Wohl M, Benson DF (1997) Behavioral phenomenology in Alzheimer's disease, frontotemporal dementia, and late-life depression: A retrospective analysis. J Geriatr Psychiatry Neurol 10, 67-74.
19. Bozeat S, Gregory CA, Ralph MAL, Hodges JR (2000) Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry 69, 178-186.
20. Snowden J, Bathgate D, Varma A, Blackshaw A, Gibbons ZC, Neary D (2001) Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry 70, 323-332.
21. Bathgate D, Snowden J, Varma A, Blackshaw A, Neary D (2001) Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol Scand 103, 367-378.
22. Rascovsky K, Hodges JR, Knopman DS, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EGP,Onyike CU, Hillis AE, Josephs KA, Boeve BF,Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini M-LL, Rosen HJ, Prioleau-Latham CEC, Lee AA, Kipps CM, Lillo PP, Piguet OO, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert FF, Pijnenburg YA, Chow TW, Manes F, Grafman JJ, Cappa SF, Freedman M, Grossman M, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456-2477.
23. Gorno-Tempini M-LL, Hillis AE, Weintraub S, Kertesz A, Mendez MF, Cappa SF, Ogar JM, Rohrer JD, Black SE, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam M, Grossman M (2011) Classification of primary progressive aphasia and its variants. Neurology 76, 1006-1014.
24. American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th edition, American Psychiatric Publishing, Washington, DC.
25. Ropacki SA, Jeste DV (2005) Epidemiology of and risk factors for psychosis of Alzheimer's disease: A review of 55 studies published from 1990 to 2003. Am J Psychiatry 162, 2022-2030.
26. Gregory CA (1999) Frontal variant of frontotemporal dementia: A cross-sectional and longitudinal study of neuropsychiatric features. Psychol Med 29, 1205-1217.
27. Hirono N, Mori E, Tanimukai S, Kazui H, Hashimoto M, Hanihara T, Imamura T (1999) Distinctive neurobehavioral features among neurodegenerative dementias. J Neuropsychiatry Clin Neurosci 11, 498-503.
28. Mendez MF (2006) Functional neuroimaging and presenting psychiatric features in frontotemporal dementia. J Neurol Neurosurg Psychiatry 77, 4-7.
29. Lopez OL, Gonzalez MP, Becker JT, Charles R, Sudilovsky A, DeKosky ST (1996) Symptoms of depression and psychosis in Alzheimer's disease and frontotemporal dementia. Neuropsychiatry Neuropsychol Behav Neurol 9, 154-161.
30. Engelborghs SS, Maertens K, Nagels G, Vloeberghs E, Marïen P, Symons A, Ketels V, Estercam S, Somers N, De Deyn P (2005) Neuropsychiatric symptoms of dementia: Cross-sectional analysis from a prospective, longitudinal Belgian study. Int J Geriatr Psychiatry 20, 1028-1037.
31. Le Ber I, Guedj E, Gabelle A, Verpillat P, Volteau M, Thomas-Antérion C, Decousus M, Hannequin D, Véra P, Lacomblez L, Camuzat A, Didic M, Puel M, Lotterie J-A, Golfier V, Bernard A-M, Vercelletto M, Magne C, Sellal F, Namer I, Michel B-F, Pasquier J, Salachas F, Bochet J, French Research Network on FTD, FTD-MND, Brice A, Habert M-O, Dubois B (2006) Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain 129, 3051-3065.
32. Omar R, Sampson EL, Loy CT, Mummery CJ, Fox NC, Rossor MN,Warren JD (2009) Delusions in frontotemporal lobar degeneration. J Neurol 256, 600-607.
33. Boone KB, Miller BL, Swartz RR, Lu PP, Lee AA (2003) Relationship between positive and negative symptoms and neuropsychological scores in frontotemporal dementia and Alzheimer's disease. J Int Neuropsychol Soc 9, 698-709.
34. Cummings JL, Mega MS, Gray KK, Rosenberg-Thompson SS, Carusi DAD, Gornbein JJ (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 44, 2308-2314.
35. Levy ML, Miller BL, Cummings JL, Fairbanks LA, Craig AA (1996) Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol 53, 687-690.
36. Liu W, Miller BL, Kramer JH, Rankin KP, Wyss-Coray C, Gearhart R, Phengrasamy L, Weiner M, Rosen HJ (2004) Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology 62, 742-748.
37. Mourik JC, Rosso SM, Niermeijer MF, Duivenvoorden HJ, van Swieten JC, Tibben A (2004) Frontotemporal dementia: Behavioral symptoms and caregiver distress. Dement Geriatr Cogn Disord 18, 299-306.
38. Mendez MF, Lauterbach ECE, Sampson SMS (2008) An evidence-based review of the psychopathology of frontotemporal dementia: A report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci 20, 130-149.
39. Rosen HJ, Gorno-Tempini M-LL, Goldman WP, Perry RJ, Schuff N, Weiner M, Feiwell RR, Kramer JH, Miller BL (2002) Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 58, 198-208.
40. Velakoulis D, Walterfang M, Mocellin R, Pantelis C, McLean C (2009) Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: Clinicopathological series and reviewof cases. Br J Psychiatry 194, 298-305.
41. Mendez MF, Fras IAI, Kremen SA, Tsai P-H (2011) False reports from patients with frontotemporal dementia: Delusions or confabulations? Behav Neurol 24, 237-244.
42. Passant U, Elfgren C, Englund E, Gustafson L (2005) Psychiatric symptoms and their psychosocial consequences in frontotemporal dementia. Alzheimer Dis Assoc Disord 19(Suppl 1), S15-S18.
43. Ibach B, Poljansky S, Barta W, Koller M, Wittmann M, Hajak G (2004) Patterns of referring of patients with frontotemporal lobar degeneration to psychiatric in- and out-patient services. Dement Geriatr Cogn Disord 17, 269-273.
44. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, Kovacs GG, Ghetti B, Halliday GM, Holm IE, Ince PG, Kamphorst W, Revesz T, Rozemuller AJM, Kumar-Singh S, Akiyama H, Baborie A, Spina S, Dickson DW, Trojanowski JQ, Mann DMA (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: An update. Acta Neuropathol 119, 1-4.
45. Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Plessis Du D, Jaros E, Perry RH, Trojanowski JQ, Mann DMA,LeeVMY(2011)Aharmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122, 111-113.
46. Waddington JL, Youssef HA, Farrell MA, Toland J (1995) Initial 'schizophrenia-like' psychosis in Pick's disease: Case study with neuroimaging and neuropathology, and implications for frontotemporal dysfunction in schizophrenia. Schizophr Res 18, 79-82.
47. Kremen SA, Solis OE, Shapira J, Vinters HV, Mendez MF (2010) "Fantastic thinking" in pathologically proven Pick disease. Cogn Behav Neurol 23, 130-134.
48. Khan BK,Woolley JD, Chao S, See T, Karydas AM, Miller BL, Rankin KP (2012) Schizophrenia or neurodegenerative disease prodrome? Outcome of a first psychotic episode in a 35-year-old woman. Psychosomatics 53, 280-284.
49. Tartaglia MC, Kertesz A, Ang L-C (2008) Delusions and hallucinations in frontotemporal dementia: A clinicopathologic case report. Cogn Behav Neurol 21, 107-110.
50. Loy CT, Kril J, Trollor JN, Kiernan MC, Kwok JB, Vucic S, Halliday GM, Hodges JR (2010) The case of a 48 year-old woman with bizarre and complex delusions. Nat Rev Neurol 6, 175-179.
51. Claassen DO, Parisi JE, Giannini C, Boeve BF, Dickson DW, Josephs KA (2008) Frontotemporal dementia mimicking dementia with Lewy bodies. Cogn Behav Neurol 21, 157-163.
52. Urwin HH, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, Authier A, Seelaar H, van Swieten JC, Brown JM, Johannsen PP, Nielsen JEJ, Holm IE, Dickson DW, Rademakers R, Graff-Radford NR, Parisi JE, Petersen RC, Hatanpaa KJ, White CL, Weiner MF, Geser FF, Van Deerlin VM, Trojanowski JQ, Miller BL, Seeley WW, van der Zee J, Kumar-Singh S, Engelborghs SS, De Deyn P, Van Broeckhoven C, Bigio EH, Deng H-XH, Halliday GM, Kril J, Munoz DG, Mann DMA, Pickering-Brown SM, Doodeman VV, Adamson GG, Ghazi-Noori SS, Fisher EMCE, Holton JLJ, Revesz T, Rossor MN, Collinge J, Mead S, Isaacs AM (2010) FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol 120, 33-41.
53. Rohrer JD, Lashley T, Schott JM,Warren JE, Mead S, Isaacs AM, Beck J, Hardy J, de Silva R, Warrington EE, Troakes CC, Al-Sarraj SS, King AA, Borroni B, Clarkson MJM, Ourselin SS, Holton JLJ, Fox NC, Revesz T, Rossor MN, Warren JD (2011) Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 134, 2565-2581.
54. Liscić RM, Storandt MM, Cairns NJ, Morris JC (2007) Clinical and psychometric distinction of frontotemporal and Alzheimer dementias. Arch Neurol 64, 535-540.
55. Mendez MF, Joshi AA, Tassniyom KK, Teng E, Shapira J (2013) Clinicopathologic differences among patients with behavioral variant frontotemporal dementia. Neurology 80, 561-568.
56. Borroni B, Alberici A, Archetti S, Magnani E, Di Luca M, Padovani A (2010) New insights into biological markers of frontotemporal lobar degeneration spectrum. Curr Med Chem 17, 1002-1009.
57. Rohrer JD, Guerreiro R,Vandrovcova J, Uphill J, Reiman D, Beck J, Isaacs AM, Authier A, Ferrari R, Fox NC, Mackenzie IR, Warren JD, de Silva R, Holton J, Revesz T, Hardy J, Mead S, Rossor MN (2009) The heritability and genetics of frontotemporal lobar degeneration. Neurology 73, 1451-1456.
58. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: A review. J Neurol Neurosurg Psychiatry 82, 476-486.
59. Momeni P, Wickremaratchi MM, Bell J, Arnold R, Beer R, Hardy J, Revesz T, Neal JW, Morris HR (2010) Clinical Neurology and Neurosurgery. Clin Neurol Neurosurg 112, 917-920.
60. Rohrer JD, Warren JD (2011) Phenotypic signatures of genetic frontotemporal dementia. Curr Opin Neurol 24, 542-549.
61. Arosio B, Abbate C, Galimberti D, Rossi PD, Inglese S, Fenoglio C, Ridolfi E, Gussago C, Casati M, Tedone E, Ferri E, Serpente M, Scarpini E, Mari D (2013) GRN Thr272fs clinical heterogeneity: A case with atypical late onset presenting with a dementia with Lewy bodies phenotype. J Alzheimers Dis 35, 669-674.
62. Momeni P, DeTucci K, Straub RE, Weinberger DR, Davies P, Grafman J, Hardy J, Huey ED (2010) Progranulin (GRN) in two siblings of a Latino family and in other patients with Schizophrenia. Neurocase 16, 273-279.
63. Le Ber I, van der Zee J, Hannequin D, Gijselinck I, Campion D, Puel M, Laquerrière A, De Pooter T, Camuzat A, Van den Broeck M, Dubois B, Sellal F, Lacomblez L,Vercelletto M, Thomas-Antérion C, Michel B-F, Golfier V, Didic M, Salachas F, Duyckaerts C, Cruts M, Verpillat P, Van BroeckhovenC, Brice A, French Research Network on FTD, FTD-MND (2007) Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat 28, 846-855.
64. Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet Lecrux A, Hahn-Barma V, van der Zee J, Clot F, Bakchine S, Puel M, Ghanim M, Lacomblez L, Mikol J, Deramecourt V, Lejeune P, la Sayette de V, Belliard S, Vercelletto M, Meyrignac C, Van Broeckhoven C, Lambert J-C, Verpillat P, Campion D, Habert M-O, Dubois B, Brice A, French Research Network on FTD, FTD-MND (2008) Phenotype variability in progranulin mutation carriers: A clinical, neuropsychological, imaging and genetic study. Brain 131, 732-746.
65. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker MC, Rutherford NJ, Nicholson AM, Finch NA, Flynn HH, Adamson J, Kouri NN, Wojtas A, Sengdy P, Hsiung G-YR, Karydas AA, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman HH, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, RademakersR(2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245-256.
66. Renton A, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas LL, Kalimo HH, Paetau AA, Abramzon Y, Remes AM, Kaganovich AA, Scholz SWS, Duckworth JJ, Ding JJ, Harmer DWD, Hernandez D, Johnson JO, Mok K, Ryten MM, Trabzuni DD, Guerreiro R, Orrell RWR, Neal JJ, Murray A, Pearson JJ, Jansen IEI, Sondervan DD, Seelaar H, Blake DD, Young KK, Halliwell NN, Callister JB, Toulson GG, Richardson AA, Gerhard AA, Snowden J, Mann DMA, Neary D, Nalls MAM, Peuralinna TT, Jansson LL, Isoviita V-MV, Kaivorinne A-LA, Hölttä-Vuori MM, Ikonen EE, Sulkava RR, Benatar MM, Wuu JJ, Chiò A, Restagno G, Borghero G, Sabatelli MM, Heckerman DD, Rogaeva E, Zinman LL, Rothstein JDJ, Sendtner MM, Drepper CC, Eichler EEE, Alkan CC, Abdullaev ZZ, Pack SDS, Dutra AA, Pak EE, Hardy J, Singleton AA,Williams NM, Heutink P, Pickering- Brown SM, Morris HR, Tienari PJP, Traynor BJ (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257-268.
67. Dobson-Stone C, Hallupp M, Bartley L, Shepherd CE, Halliday GM, Schofield PR, Hodges JR, Kwok JB (2012) C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology 79, 995-1001.
68. Khan BK, Yokoyama JS, Takada LT, Sha SJ, Rutherford NJ, Fong JC, Karydas A,Wu T, Ketelle R, Baker MC, DeJesus- Hernandez M, Coppola G, Geschwind DH, Rademakers R, Lee SE, Rosen HJ, Rabinovici GD, Seeley WW, Rankin KP, Boxer AL, Miller BL (2012) Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatry 83, 358-364.
69. Takada LT, Pimentel MLVM, DeJesus-Hernandez M, Fong JC, Yokoyama JS, Karydas AA, Thibodeau M-PM, Rutherford NJ, BakerMC,Lomen-Hoerth C, Rademakers R, Miller BL (2012) Frontotemporal dementia in a Brazilian kindred with the c9orf72 mutation. Arch Neurol 69, 1149-1153.
70. Takada LT, Sha SJ (2012) Neuropsychiatric features of C9orf72-associated behavioral variant frontotemporal dementia and frontotemporal dementia with motor neuron disease. Alzheimers Res Ther 4, 38-38.
71. Arighi A, Fumagalli GG, Jacini FF, Fenoglio CC, Ghezzi L, Pietroboni AMA, De Riz MM, Serpente M, Ridolfi EE, Bonsi R, Bresolin N, Scarpini E, Galimberti D (2012) Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: Psychiatric clinical presentations. J Alzheimers Dis 31, 447-452.
72. Larner AJ (2013) Delusion of pregnancy: A case revisited. Behav Neurol 27, 293-294.
73. Floris G, Borghero G, Cannas A, Stefano FD, Murru MR, Corongiu D, Cuccu S, Tranquilli S, Marrosu MG, Chiò A, Marrosu F (2013) Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: Is there a genetic link between these two disorders? J Neurol 260, 1155-1157.
74. Simón-Sánchez J, Dopper EGP, Cohn-Hokke PE, Hukema RK, Nicolaou N, Seelaar H, de Graaf JRA, de Koning I, van Schoor NM, Deeg DJH, Smits M, Raaphorst J, van den Berg LH, Schelhaas HJ, De Die-Smulders CEM, Majoor- Krakauer D, Rozemuller AJM, Willemsen R, Pijnenburg YA, Heutink P, van Swieten JC (2012) The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain 135, 723-735.
75. Hsiung G-YR, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, Dwosh E, Butler R, Leung B, Fok A, Rutherford NJ, Baker MC, Rademakers R, Mackenzie IR (2012) Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain 135, 709-722.
76. Mosca L, Lunetta C, Tarlarini C, Avemaria F, Maestri E, Melazzini M, Corbo M, Penco S (2012) Wide phenotypic spectrum of the TARDBP gene: Homozygosity of A382T mutation in a patient presenting with amyotrophic lateral sclerosis, Parkinson's disease, and frontotemporal lobar degeneration, and in neurologically healthy subject. Neurobiol Aging 33, 1846.e1-4.
77. Tang-Wai DF, Lewis P, Boeve BF, Hutton M, Golde T, Baker M, Hardy J, Michels V, Ivnik RJ, Jack CR, Petersen RC (2002) Familial frontotemporal dementia associated with a novel presenilin-1 mutation. Dement Geriatr Cogn Disord 14, 13-21.
78. Gourzis P, Skokou M, Polychronopoulos P, Soubasi E, Triantaphyllidou IE, Aravidis C, Sarela A-I, Kosmaidou Z (2012) Frontotemporal dementia, manifested as schizophrenia, with decreased heterochromatin on chromosome 1. Case Rep Psychiatry 2012, 937518.
79. Mahoney CJ, Downey LE, Ridgway GR, Beck J, Clegg S, Blair M, Finnegan S, Leung KK, Yeatman T, Golden H, Mead S, Rohrer JD, Fox NC, Warren JD (2012) Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. Alzheimers Res Ther 4, 41.
80. Chan D, Anderson V, Pijnenburg YA, Whitwell JL, Barnes J, Scahill R, Stevens JM, Barkhof F, Scheltens P, Rossor MN, Fox NC (2009) The clinical profile of right temporal lobe atrophy. Brain 132, 1287-1298.
81. Pennington C, Hodges JR, Hornberger M (2011) Neural correlates of episodic memory in behavioral variant frontotemporal dementia. J Alzheimers Dis 24, 261-268.
82. Davies R, Kipps CM, Mitchell J, Kril J, Halliday GM, Hodges JR (2006) Progression in frontotemporal dementia: Identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol 63, 1627-1631.
83. Kipps CM, Nestor PJ, Fryer TD, Hodges JR (2007) Behavioural variant frontotemporal dementia: Not all it seems? Neurocase 13, 237-247.
84. HuB, Ross LL, Neuhaus J, Knopman DS, Kramer JH, Boeve BF, Caselli RJ, Graff-Radford NR, Mendez MF, Miller BL, Boxer AL (2010) Off-label medication use in frontotemporal dementia. Am J Alzheimers Dis Other Demen 25, 128-133.
85. Caselli RJ, Yaari R (2008) Medical Management of Frontotemporal Dementia. Am J Alzheimers Dis Other Demen 22, 489-498.
86. Mendez MF (2009) Frontotemporal dementia: Therapeutic interventions. Front Neurol Neurosci 24, 168-178.
87. Kobayashi T, Inoue K, Shioda K, Kato S (2012) Effectiveness of electroconvulsive therapy for depression and Cotard's syndrome in a patient with frontotemporal lobe dementia. Case Rep Psychiatry 2012, 1-4.
88. Fázzari G, Benzoni O, Sangaletti A, Bonera F, Nassini S, Mazzarini L, Pacchiarotti I, Sani G,Koukopoulos AE, Sanna L, Gasparotti R, De Rossi P, Lazanio S, Savoja V, Girardi P (2009) Improvement of cognition in a patient with Cotard's delusions and frontotemporal atrophy receiving electroconvulsive therapy (ECT) for depression. Int Psychogeriatr 21, 600.
89. Kimura T, Hayashida H, Murata M, Takamatsu J (2011) Effect of ferulic acid and Angelica archangelica extract on behavioral and psychological symptoms of dementia in frontotemporal lobar degeneration and dementia with Lewy bodies. Geriatr Gerontol Int 11, 309-314.
90. Kimura T, Hayashida H, Furukawa H, Miyauchi D, Takamatsu J (2009) Five cases of frontotemporal dementia with behavioral symptoms improved by Yokukansan. Psychogeriatrics 9, 38-43.
91. Kerssens CJ, Kerrsens CJ, Pijnenburg YA (2008) Vulnerability to neuroleptic side effects in frontotemporal dementia. Eur J Neurol 15, 111-112.
92. Nakajima S, Gerretsen P, Takeuchi H, Caravaggio F, Chow TW, Le Foll B, Mulsant B, Pollock B, Graff-Guerrero A (2013) The potential role of dopamine D3 receptor neurotransmission in cognition. Eur Neuropsychopharmacol 23, 799-813.
93. Miller DD, McEvoy JP, Davis SM, Caroff SN, Saltz BL, Chakos MH, Swartz MS, Keefe RS, Rosenheck RA, Stroup TS, Lieberman JA (2005) Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trial. Schizophr Res 80, 33-43.
94. Novick DD, Haro JMJ, Bertsch JJ, Haddad PMP (2010) Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: Thirty-six-month results from the European schizophrenia outpatient health outcomes study. J Clin Psychopharmacol 30, 531-540.
95. Pose M, Cetkovich M, Gleichgerrcht E, Ibáñez A, Torralva T, Manes F (2013) The overlap of symptomatic dimensions between frontotemporal dementia and several psychiatric disorders that appear in late adulthood. Int Rev Psychiatry 25, 159-167.
96. Fornito A, Yücel M, Pantelis C (2009) Reconciling neuroimaging and neuropathological findings in schizophrenia and bipolar disorder. Curr Opin Psychiatry 22, 312-319.
97. Olabi BB, Ellison-Wright I, Bullmore ET, Lawrie SMS (2012) Structural brain changes in first episode schizophrenia compared with fronto-temporal lobar degeneration: A meta-analysis. BMC Psychiatry 12, 104-104.
98. BrownGG,ThompsonWK(2010) Functional brain imaging in schizophrenia: Selected results and methods. Curr Top Behav Neurosci 4, 181-214.
99. Kalkstein SS, Hurford II, Gur RCR (2010) Neurocognition in schizophrenia. Curr Top Behav Neurosci 4, 373-390.
100. Schoder D, Hannequin D, Martinaud O, Opolczynski G, Guyant-Marechal L, Le Ber I, Campion D (2010) Morbid risk for schizophrenia in first-degree relatives of people with frontotemporal dementia. Br J Psychiatry 197, 28-35.
101. Huey ED, Nagy PL, Rodriguez-Murillo L, Manoochehri M, Goldman JS, Lieberman J, Karayiorgou M, Mayeux R (2013) C9ORF72 repeat expansions not detected in a group of patients with schizophrenia. Neurobiol Aging 34, 1309.e9-10.
102. Cooper JJ, Ovsiew F (2013) The relationship between schizophrenia and frontotemporal dementia. J Geriatr Psychiatry Neurol 26, 131-137.
103. Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, Chatterjee A, Hurtig HI, Karlawish JH, Rosen HJ, Van Deerlin VM, Lee VMY, Miller BL, Trojanowski JQ, GrossmanM(2006) Frontotemporal dementia: Clinicopathological correlations. Ann Neurol 59, 952-962.
104. Kapur S, Agid O, Mizrahi R, Li M (2006) How antipsychotics work-from receptors to reality. NeuroRx 3, 10-21.
105. Vukadinovic Z, Rosenzweig I (2012) Abnormalities in thalamic neurophysiology in schizophrenia: Could psychosis be a result of potassium channel dysfunction? Neurosci Biobehav Rev 36, 960-968.
106. Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, Kapur S (2012) The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry 69, 776-786.
107. Poels EMP, Kegeles LS, Kantrowitz JT, Slifstein M, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR (2014) Imaging glutamate in schizophrenia: Reviewof findings and implications for drug discovery. Mol Psychiatry 19, 20-29.
108. Huey ED, Putnam KT, Grafman J (2006) A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology 66, 17-22.
109. Nikolaus S, Antke C, Müller H-W (2009) In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia. Behav Brain Res 204, 1-31.
110. Engelborghs SS, Vloeberghs E, Le Bastard N, Van Buggenhout M, Marïen P, Somers N, Nagels G, Pickut BA, De Deyn P (2008) The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. Neurochem Int 52, 1052-1060.
111. Vermeiren Y, Le Bastard N, Van Hemelrijck A, Drinkenburg WH, Engelborghs SS, De Deyn P (2013) Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia. Alzheimers Dement 9, 488-498.
112. Ikeda M, Ishikawa T, Tanabe H (2004) Epidemiology of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 17, 265-268.
113. Wada-Isoe K, Ito S, Adachi T, Yamawaki M, Nakashita S, Kusumi M, Hiroe Y, Takada T, Watanabe K, Hikasa C, Nakashima K (2012) Epidemiological survey of frontotemporal lobar degeneration in Tottori Prefecture, Japan. Dement Geriatr Cogn Disord Extra 2, 381-386.
114. Ogaki K, Li Y, Takanashi M, Ishikawa K-I, Kobayashi T, Nonaka T, Hasegawa M, Kishi M, Yoshino H, Funayama M, Tsukamoto T, Shioya K, Yokochi M, Imai H, Sasaki R, Kokubo Y, Kuzuhara S, Motoi Y, Tomiyama H, Hattori N (2013) Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS. Parkinsonism Relat Disord 19, 15-20.
115. Kim E-J, Kwon JC, Park KH, Park K-W, Lee J-H, Choi SH, Jeong JH, Kim BC, Yoon SJ, Yoon YC, Kim S, Park K-C, Choi B-O, Na DL, Ki C-S, Kim SH (2014) Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia. Neurobiol Aging 35, 1213.e13-7.
116. KeshavanMS, Tandon R, Boutros NN, NasrallahHA(2008) Schizophrenia, "just the facts": What we know in 2008 Part 3: Neurobiology. Schizophr Res 106, 89-107.
117. Shah JN, Qureshi SU, Jawaid A, Schulz PE (2011) Is there evidence for late cognitive decline in chronic schizophrenia? Psychiatr Q 83, 127-144.
118. Rajji TK, Voineskos AN, Butters MA, Miranda D, Arenovich T, Menon M, Ismail Z, Kern RS, Mulsant BH (2013) Cognitive performance of individuals with schizophrenia across seven decades: A study using the MATRICS consensus cognitive battery. Am J Geriatr Psychiatry 21, 108-118.
119. Silveri MC, Salvigni BL, Jenner C, Colamonico P (2004) Behavior in degenerative dementias: Mood disorders, psychotic symptoms and predictive value of neuropsychological deficits. Arch Gerontol Geriatr 38, 365-378.
120. Lillo P, Garcin B, Hornberger M, Bak TH, Hodges JR (2010) Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol 67, 826-830.
121. Galimberti D, Fenoglio C, Serpente M, Villa C, Bonsi R, Arighi A, Fumagalli GG, Del Bo R, Bruni AC, Anfossi M, Clodomiro A, Cupidi C, Nacmias B, Sorbi S, Piaceri I, Bagnoli S, Bessi V, Marcone A, Cerami C, Cappa SF, Filippi M, Agosta F, Magnani G, Comi G, Franceschi M, Rainero I, Giordana MT, Rubino E, Ferrero P, Rogaeva E, Xi Z, Confaloni A, Piscopo P, Bruno G, Talarico G, Cagnin A, Clerici F, Osso BDX, Comi G, Altamura AC,Mariani C, Scarpini E (2013) Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: Late-onset psychotic clinical presentation. Biol Psychiatry 74, 384-391.
122. Le Ber I, Camuzat AA, Guillot-Noel LL, Hannequin D, Lacomblez L, Golfier VV, Puel M, Martinaud O, Deramecourt V, Rivaud-Pechoux SS, Millecamps SS, Vercelletto M, Couratier PP, Sellal F, Pasquier F, Salachas F, Thomas- Antérion C, Didic MM, Pariente JJ, Seilhean DD, Ruberg MM, Wargon II, Blanc FF, Camu WW, Michel B-F, Berger EE, SauvéeMM,Thauvin-Robinet CC, Mondon KK, Tournier-Lasserve EE, Goizet CC, FleuryMM,Viennet GG, Verpillat P, Meininger VV, Duyckaerts C, Dubois B, Brice AA(2013) C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: A flow-chart for genetic testing. J Alzheimers Dis 34, 485-499.